US Stock MarketDetailed Quotes

BioCryst Pharmaceuticals (BCRX)

Watchlist
  • 9.020
  • -0.550-5.75%
Close May 15 16:00 ET
  • 9.020
  • 0.0000.00%
Post 16:04 ET
2.29BMarket Cap-5.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioCryst Pharmaceuticals (BCRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
7.48%156.41M
94.10%874.84M
209.09%406.56M
36.14%159.4M
49.41%163.35M
56.89%145.53M
36.00%450.71M
40.83%131.53M
34.98%117.09M
32.54%109.33M
Operating revenue
12.75%151.36M
94.10%874.84M
209.09%406.56M
36.14%159.4M
49.41%163.35M
44.72%134.24M
36.00%450.71M
36.58%131.53M
36.65%117.09M
32.54%109.33M
Cost of revenue
17.71%5.38M
55.47%19.08M
56.25%9.52M
-31.89%2.19M
64.69%2.8M
261.11%4.57M
173.80%12.27M
318.26%6.09M
182.66%3.21M
78.84%1.7M
Gross profit
7.14%151.04M
95.18%855.76M
216.51%397.03M
38.05%157.21M
49.17%160.56M
54.07%140.97M
34.11%438.44M
36.43%125.44M
33.02%113.87M
32.00%107.63M
Operating expense
612.08%852.63M
16.73%514.77M
5.16%136.65M
20.19%127.62M
32.26%130.77M
12.98%119.74M
2.40%440.99M
-3.47%129.95M
8.87%106.18M
-3.30%98.87M
Selling and administrative expenses
14.65%94.55M
30.90%348.65M
18.97%95.78M
27.52%83.01M
42.67%87.38M
38.62%82.47M
24.42%266.35M
24.70%80.51M
28.54%65.1M
20.10%61.25M
Research and development costs
1,934.02%758.08M
-4.87%166.13M
-17.34%40.87M
8.57%44.6M
15.32%43.39M
-19.84%37.27M
-19.36%174.64M
-29.42%49.44M
-12.37%41.08M
-26.58%37.62M
Operating profit
-3,405.22%-701.6M
13,508.93%340.99M
5,876.06%260.39M
284.70%29.59M
239.98%29.79M
246.51%21.23M
97.55%-2.54M
89.44%-4.51M
164.52%7.69M
142.32%8.76M
Net non-operating interest income expense
14.40%-17.52M
18.58%-68.2M
46.14%-11.25M
17.96%-17.42M
9.98%-19.07M
0.02%-20.47M
9.40%-83.77M
-3.78%-20.88M
8.31%-21.24M
15.84%-21.18M
Non-operating interest income
-25.40%2.26M
-27.65%10.67M
-19.05%2.89M
-37.68%2.24M
-29.21%2.52M
-24.98%3.02M
-6.53%14.75M
-20.04%3.57M
-14.17%3.59M
-5.23%3.55M
Non-operating interest expense
-15.81%19.78M
-19.94%78.87M
-42.19%14.14M
-20.81%19.66M
-12.74%21.58M
-4.13%23.49M
-8.98%98.52M
-0.55%24.45M
-9.20%24.83M
-14.46%24.73M
Other net income (expense)
-168,800.00%-1.69M
-741.50%-5.39M
-85.93%-1.12M
-138.78%-38K
-4,940.48%-4.23M
101.96%1K
97.87%-641K
-61.50%-604K
113.30%98K
99.71%-84K
Gain on sale of security
-22,600.00%-225K
76.29%-152K
79.30%-125K
-64.29%35K
25.00%-63K
101.96%1K
38.31%-641K
-61.50%-604K
113.30%98K
-127.91%-84K
Special income (charges)
----
---17.33M
---10.42M
---2.74M
---4.17M
----
--0
--0
--0
--0
-Less:Other special charges
----
--17.33M
--10.42M
--2.74M
--4.17M
----
----
----
----
----
Other non- operating income (expenses)
---1.46M
--12.09M
--9.42M
--2.67M
----
----
----
----
----
----
Income before tax
-95,193.40%-720.81M
407.51%267.39M
1,054.24%248.02M
190.21%12.13M
151.88%6.49M
102.16%758K
61.56%-86.95M
58.85%-25.99M
62.46%-13.45M
83.24%-12.5M
Income tax
38.29%1M
83.19%3.53M
170.15%2.17M
-231.23%-769K
714.53%1.4M
98.90%726K
521.61%1.93M
156.18%804K
77.58%586K
-76.76%172K
Net income
-2,255,762.50%-721.81M
396.87%263.86M
1,017.50%245.85M
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
Net income continuous Operations
-2,255,762.50%-721.81M
396.87%263.86M
1,017.50%245.85M
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
Minority interest income
Net income attributable to the parent company
-2,255,762.50%-721.81M
396.87%263.86M
1,017.50%245.85M
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-2,255,762.50%-721.81M
396.87%263.86M
1,017.50%245.85M
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
Basic earnings per share
-2.98
393.02%1.26
1,000.00%1.17
185.71%0.06
133.33%0.02
0
63.56%-0.43
58.06%-0.13
63.16%-0.07
85.00%-0.06
Diluted earnings per share
-2.98
381.40%1.21
961.54%1.12
185.71%0.06
133.33%0.02
0
63.56%-0.43
58.06%-0.13
63.16%-0.07
85.00%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 7.48%156.41M94.10%874.84M209.09%406.56M36.14%159.4M49.41%163.35M56.89%145.53M36.00%450.71M40.83%131.53M34.98%117.09M32.54%109.33M
Operating revenue 12.75%151.36M94.10%874.84M209.09%406.56M36.14%159.4M49.41%163.35M44.72%134.24M36.00%450.71M36.58%131.53M36.65%117.09M32.54%109.33M
Cost of revenue 17.71%5.38M55.47%19.08M56.25%9.52M-31.89%2.19M64.69%2.8M261.11%4.57M173.80%12.27M318.26%6.09M182.66%3.21M78.84%1.7M
Gross profit 7.14%151.04M95.18%855.76M216.51%397.03M38.05%157.21M49.17%160.56M54.07%140.97M34.11%438.44M36.43%125.44M33.02%113.87M32.00%107.63M
Operating expense 612.08%852.63M16.73%514.77M5.16%136.65M20.19%127.62M32.26%130.77M12.98%119.74M2.40%440.99M-3.47%129.95M8.87%106.18M-3.30%98.87M
Selling and administrative expenses 14.65%94.55M30.90%348.65M18.97%95.78M27.52%83.01M42.67%87.38M38.62%82.47M24.42%266.35M24.70%80.51M28.54%65.1M20.10%61.25M
Research and development costs 1,934.02%758.08M-4.87%166.13M-17.34%40.87M8.57%44.6M15.32%43.39M-19.84%37.27M-19.36%174.64M-29.42%49.44M-12.37%41.08M-26.58%37.62M
Operating profit -3,405.22%-701.6M13,508.93%340.99M5,876.06%260.39M284.70%29.59M239.98%29.79M246.51%21.23M97.55%-2.54M89.44%-4.51M164.52%7.69M142.32%8.76M
Net non-operating interest income expense 14.40%-17.52M18.58%-68.2M46.14%-11.25M17.96%-17.42M9.98%-19.07M0.02%-20.47M9.40%-83.77M-3.78%-20.88M8.31%-21.24M15.84%-21.18M
Non-operating interest income -25.40%2.26M-27.65%10.67M-19.05%2.89M-37.68%2.24M-29.21%2.52M-24.98%3.02M-6.53%14.75M-20.04%3.57M-14.17%3.59M-5.23%3.55M
Non-operating interest expense -15.81%19.78M-19.94%78.87M-42.19%14.14M-20.81%19.66M-12.74%21.58M-4.13%23.49M-8.98%98.52M-0.55%24.45M-9.20%24.83M-14.46%24.73M
Other net income (expense) -168,800.00%-1.69M-741.50%-5.39M-85.93%-1.12M-138.78%-38K-4,940.48%-4.23M101.96%1K97.87%-641K-61.50%-604K113.30%98K99.71%-84K
Gain on sale of security -22,600.00%-225K76.29%-152K79.30%-125K-64.29%35K25.00%-63K101.96%1K38.31%-641K-61.50%-604K113.30%98K-127.91%-84K
Special income (charges) -------17.33M---10.42M---2.74M---4.17M------0--0--0--0
-Less:Other special charges ------17.33M--10.42M--2.74M--4.17M--------------------
Other non- operating income (expenses) ---1.46M--12.09M--9.42M--2.67M------------------------
Income before tax -95,193.40%-720.81M407.51%267.39M1,054.24%248.02M190.21%12.13M151.88%6.49M102.16%758K61.56%-86.95M58.85%-25.99M62.46%-13.45M83.24%-12.5M
Income tax 38.29%1M83.19%3.53M170.15%2.17M-231.23%-769K714.53%1.4M98.90%726K521.61%1.93M156.18%804K77.58%586K-76.76%172K
Net income -2,255,762.50%-721.81M396.87%263.86M1,017.50%245.85M191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M
Net income continuous Operations -2,255,762.50%-721.81M396.87%263.86M1,017.50%245.85M191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M
Minority interest income
Net income attributable to the parent company -2,255,762.50%-721.81M396.87%263.86M1,017.50%245.85M191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -2,255,762.50%-721.81M396.87%263.86M1,017.50%245.85M191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M
Basic earnings per share -2.98393.02%1.261,000.00%1.17185.71%0.06133.33%0.02063.56%-0.4358.06%-0.1363.16%-0.0785.00%-0.06
Diluted earnings per share -2.98381.40%1.21961.54%1.12185.71%0.06133.33%0.02063.56%-0.4358.06%-0.1363.16%-0.0785.00%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.04%
Sample Name
Sample Code
 +27.71%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.41%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.36%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -